Eagle Pharmaceuticals Announces FDA Accepts RTU Bivalirudin NDA for Filing By: Benzinga via Benzinga July 23, 2015 at 07:10 AM EDT Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that the 505(b)(2) New Drug Application (NDA) for its novel ... Read More >> Related Stocks: Eagle Pharmaceuticals